Trial Profile

Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE) INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 20 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 Jan 2022 The protocol was amended to exclude the incorporation of Abiraterone Acetate With Prednisone along with Apalutamide and Advanced Imaging.
07 Jan 2022 Status changed from suspended to recruiting.
22 Sep 2021 Status changed from recruiting to suspended due to design change.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com